• Join
  • Login
  • Contact

Search abstracts

The role of cost-effectiveness analyses in selection of medicines for national insurance schemes and national essential medicines list: Process and country examples

  • At: Salvadore (Brazil) (2006)
  • Type: Presentation
  • By: WANING, Brenda (Boston University, International Health, Cambridge, United States of America)
  • Abstract:

    Limited resources for medicines require cost considerations be made at all levels of the health care system including national, facility, program, practitioner, and consumer levels. Cost-effectiveness analyses have been widely used by policy makers in many developed countries to guide decisions about medicine coverage. In developing and


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses